Ronald R. Bowsher
0000-0002-3137-2478
Publication & Citation Trends
Publications
0 total
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin. OA
Cited by 6
Semantic Scholar
Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines OA
Cited by 3
Semantic Scholar
Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials OA
Cited by 18
Semantic Scholar
ODP178 Development and Validation of a Noncompetitive Immunoassay Optimized for the Assessment of Pharmacokinetics of Biologically Active Efruxifermin in Humans OA
Cited by 0
Semantic Scholar
34920 Clinical immunogenicity of daxibotulinumtoxinA for injection (DAXI) in glabellar lines including subjects with multiple exposures: Pooled data from the SAKURA phase 3 trials
Cited by 0
Semantic Scholar
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain OA
Cited by 7
Semantic Scholar
A bridging assay for detection and characterization of anti-drug antibodies to dostarlimab, a new anti-PD-1 therapeutic monoclonal antibody OA
Cited by 0
Semantic Scholar
FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein OA
Cited by 7
Semantic Scholar
Anti-drug Antibody Validation Testing and Reporting Harmonization OA
Cited by 58
Semantic Scholar
Research Topics
Biosimilars and Bioanalytical Methods
(29)
Monoclonal and Polyclonal Antibodies Research
(22)
Advanced Biosensing Techniques and Applications
(19)
Diabetes Management and Research
(13)
Polyamine Metabolism and Applications
(11)
Affiliations
Kaiser Permanente
University of California, Los Angeles
The University of Texas Health Science Center at San Antonio
Eli Lilly (United States)
East Carolina University